|
1
|
Mizoguchi T, Muto A, Udagawa N, Arai A,
Yamashita T, Hosoya A, Ninomiya T, Nakamura H, Yamamoto Y, Kinugawa
S, et al: Identification of cell cycle-arrested quiescent
osteoclast precursors in vivo. J Cell Biol. 184:541–554. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goldring SR and Gravallese EM: Mechanisms
of bone loss in inflammatory arthritis: Diagnosis and therapeutic
implications. Arthritis Res. 2:33–37. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takayanagi H, Ogasawara K, Hida S, Chiba
T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, et al:
T-cell-mediated regulation of osteoclastogenesis by signalling
cross-talk between RANKL and IFN-gamma. Nature. 408:600–605. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oostlander AE, Everts V, Schoenmaker T,
Bravenboer N, van Vliet SJ, van Bodegraven AA, Lips P and de Vries
TJ: T cell-mediated increased osteoclast formation from peripheral
blood as a mechanism for Crohn's disease-associated bone loss. J
Cell Biochem. 113:260–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Horowitz MC, Xi Y, Pflugh DL, Hesslein DG,
Schatz DG, Lorenzo JA and Bothwell AL: Pax5-deficient mice exhibit
early onset osteopenia with increased osteoclast progenitors. J
Immunol. 173:6583–6591. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cappariello A, Maurizi A, Veeriah V and
Teti A: The great beauty of the osteoclast. Arch Biochem Biophys.
558:70–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gillespie MT: Impact of cytokines and T
lymphocytes upon osteoclast differentiation and function. Arthritis
Res Ther. 9:1032007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tian J, Chen J, Gao J, Li L and Xie X:
Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human
rheumatoid arthritis fibroblast-like synoviocytes via modulation of
PI3kinase/Akt pathway. Rheumatol Int. 33:1829–1835. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tucci M, Stucci S, Savonarola A,
Ciavarella S, Cafforio P, Dammacco F and Silvestris F: Immature
dendritic cells in multiple myeloma are prone to osteoclast-like
differentiation through interleukin-17A stimulation. Br J Haematol.
161:821–831. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu YC, Yeh WC and Ohashi PS: LPS/TLR4
signal transduction pathway. Cytokine. 42:145–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hou GQ, Guo C, Song GH, Fang N, Fan WJ,
Chen XD, Yuan L and Wang ZQ: Lipopolysaccharide (LPS) promotes
osteoclast differentiation and activation by enhancing the MAPK
pathway and COX-2 expression in RAW264.7 cells. Int J Mol Med.
32:503–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji JD, Park-Min KH, Shen Z, Fajardo RJ,
Goldring SR, Mchugh KP and Ivashkiv LB: Inhibition of RANK
expression and osteoclastogenesis by TLRs and IFN-gamma in human
osteoclast precursors. J Immunol. 183:7223–7233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takayanagi H: Osteoimmunology: Shared
mechanisms and crosstalk between the immune and bone systems. Nat
Rev Immunol. 7:292–304. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai R and Ahmed SA: MicroRNA, a new
paradigm for understanding immunoregulation, inflammation, and
autoimmune diseases. Transl Res. 157:163–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Urbich C, Kuehbacher A and Dimmeler S:
Role of microRNAs in vascular diseases, inflammation, and
angiogenesis. Cardiovasc Res. 79:581–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mandal P, Mcmullen MR, Park PH, Roge T and
Nagy LE: Adiponectin decreases expression of TLR4 and MyD-88
independent signal transduction in RAW 264.7 macrophages. Cytokine.
48:1302009. View Article : Google Scholar
|
|
17
|
Tang P, Xiong Q, Wei G and Zhang L: The
role of microRNAs in osteoclasts and osteoporosis. RNA Biol.
11:1355–1363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim K, Kim JH, Kim I, Lee J, Seong S, Park
YW and Kim N: MicroRNA-26a regulates RANKL-induced osteoclast
formation. Mol Cells. 38:75–80. 2015.PubMed/NCBI
|
|
19
|
Li Z, Zhang W and Huang Y: MiRNA-133a is
involved in the regulation of postmenopausal osteoporosis through
promoting osteoclast differentiation. Acta Biochim Biophys Sin
(Shanghai). 50:273–280. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pauley KM, Satoh M, Chan AL, Bubb MR,
Reeves WH and Chan EK: Upregulated miR-146a expression in
peripheral blood mononuclear cells from rheumatoid arthritis.
Arthritis Res Ther. 10:R1012008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Boldin MP, Taganov KD, Rao DS, Yang L,
Zhao JL, Kalwani M, Garciaflores Y, Luong M, Devrekanli A, Xu J, et
al: miR-146a is a significant brake on autoimmunity,
myeloproliferation, and cancer in mice. J Exp Med. 208:1189–1201.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Wan Y, Guo Q, Zou L, Zhang J, Fang
Y, Zhang J, Zhang J, Fu X, Liu H, et al: Altered microRNA
expression profile with miR-146a upregulation in CD4+ T cells from
patients with rheumatoid arthritis. Arthritis Res Ther. 12:R812010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kobayashi K, Takahashi N, Jimi E, Udagawa
N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima
N, et al: Tumor necrosis factor α stimulates osteoclast
differentiation by a mechanism independent of the Odf/Rankl-Rank
interaction. J Exp Med. 191:275–286. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao Y, Grassi F, Ryan MR, Terauchi M, Page
K, Yang X, Weitzmann MN and Pacifici R: IFN-gamma stimulates
osteoclast formation and bone loss in vivo via antigen-driven T
cell activation. J Clin Invest. 117:122–132. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsu H, Lacey DL, Dunstan CR, Solovyev I,
Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, et
al: Tumor necrosis factor receptor family member RANK mediates
osteoclast differentiation and activation induced by
osteoprotegerin ligand. Proc Natl Acad Sci USA. 96:3540–3545. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kudo O, Fujikawa Y, Itonaga I, Sabokbar A,
Torisu T and Athanasou NA: Proinflammatory cytokine
(TNFalpha/IL-1alpha) induction of human osteoclast formation. J
Pathol. 198:220–227. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Taganov KD, Boldin MP, Chang KJ and
Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune
responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Di Benedetto A, Gigante I, Colucci S and
Grano M: Periodontal disease: Linking the primary inflammation to
bone loss. Clin Dev Immunol. 2013:5037542013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Romas E and Gillespie MT:
Inflammation-induced bone loss: Can it be prevented? Rheum Dis Clin
North Am. 32:759–773. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Graves DT, Li J and Cochran DL:
Inflammation and uncoupling as mechanisms of periodontal bone loss.
J Dent Res. 90:143–153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Y, Yan M, Yu QF, Yang PF, Zhang HD,
Sun YH, Zhang ZF and Gao YF: Puerarin prevents LPS-induced
osteoclast formation and bone loss via inhibition of Akt
activation. Biol Pharm Bull. 39:2028–2035. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim DY, Jun JH, Lee HL, Woo KM, Ryoo HM,
Kim GS, Baek JH and Han SB: N-acetylcysteine prevents LPS-induced
pro-inflammatory cytokines and MMP2 production in gingival
fibroblasts. Arch Pharm Res. 30:1283–1292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rossol M, Heine H, Meusch U, Quandt D,
Klein C, Sweet MJ and Hauschildt S: LPS-induced cytokine production
in human monocytes and macrophages. Crit Rev Immunol. 31:379–446.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Islam S, Hassan F, Tumurkhuu G, Dagvadorj
J, Koide N, Naiki Y, Mori I, Yoshida T and Yokochi T: Bacterial
lipopolysaccharide induces osteoclast formation in RAW 264.7
macrophage cells. Biochem Biophys Res Commun. 360:346–351. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takami M, Kim N, Rho J and Choi Y:
Stimulation by toll-like receptors inhibits osteoclast
differentiation. J Immunol. 169:1516–1523. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mörmann M, Thederan M, Nackchbandi I,
Giese T, Wagner C and Hänsch GM: Lipopolysaccharides (LPS) induce
the differentiation of human monocytes to osteoclasts in a tumour
necrosis factor (TNF) alpha-dependent manner: A link between
infection and pathological bone resorption. Mol Immunol.
45:3330–3337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Baek JM, Kim JY, Yoon KH, Oh J and Lee MS:
Ebselen is a potential anti-osteoporosis agent by suppressing
receptor activator of nuclear factor Kappa-B ligand-induced
osteoclast differentiation in vitro and lipopolysaccharide-induced
Inflammatory bone destruction in vivo. Int J Biol Sci. 12:478–488.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zou W and Bar-Shavit Z: Dual modulation of
osteoclast differentiation by lipopolysaccharide. J Bone Miner Res.
17:1211–1218. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Itoh K, Udagawa N, Kobayashi K, Suda K, Li
X, Takami M, Okahashi N, Nishihara T and Takahashi N:
Lipopolysaccharide promotes the survival of osteoclasts via
Toll-like receptor 4, but cytokine production of osteoclasts in
response to lipopolysaccharide is different from that of
macrophages. J Immunol. 170:3688–3695. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kikuchi T, Matsuguchi T, Tsuboi N, Mitani
A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T and
Yoshikai Y: Gene expression of osteoclast differentiation factor is
induced by lipopolysaccharide in mouse osteoblasts via Toll-like
receptors. J Immunol. 166:3574–3579. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kwan Tat S, Padrines M, Théoleyre S,
Heymann D and Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: Interrelations
in bone resorption pathophysiology. Cytokine Growth Factor Rev.
15:49–60. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu R, Liu C, Chen D, Yang WH, Liu X, Liu
CG, Dugas CM, Tang F, Zheng P, Liu Y and Wang L: FOXP3 controls an
miR-146/NF-κB negative feedback loop that inhibits apoptosis in
breast cancer cells. Cancer Res. 75:1703–1713. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yousefzadeh N, Alipour MR and Soufi FG:
Deregulation of NF-кB-miR-146a negative feedback loop may be
involved in the pathogenesis of diabetic neuropathy. J Physiol
Biochem. 71:51–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nakasa T, Shibuya H, Nagata Y, Niimoto T
and Ochi M: The inhibitory effect of microRNA-146a expression on
bone destruction in collagen-induced arthritis. Arthritis Rheum.
63:1582–1590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang X, Wang C, Zhao J, Xu J, Geng Y, Dai
L, Huang Y, Fu SC, Dai K and Zhang X: miR-146a facilitates
osteoarthritis by regulating cartilage homeostasis via targeting
Camk2d and Ppp3r2. Cell Death Dis. 8:e27342017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang L, Boldin MP, Yu Y, Liu CS, Ea CK,
Ramakrishnan P, Taganov KD, Zhao JL and Baltimore D: miR-146a
controls the resolution of T cell responses in mice. J Exp Med.
209:1655–1670. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cheng Y, Kuang W, Hao Y, Zhang D, Lei M,
Du L, Jiao H, Zhang X and Wang F: Downregulation of miR-27a* and
miR-532-5p and upregulation of miR-146a and miR-155 in LPS-induced
RAW264.7 macrophage cells. Inflammation. 35:1308–1313. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen G, Umelo IA, Lv S, Teugels E, Fostier
K, Kronenberger P, Dewaele A, Sadones J, Geers C and De Grève J:
miR-146a inhibits cell growth, cell migration and induces apoptosis
in non-small cell lung cancer cells. PLoS One. 8:e603172013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Russo A, Saide A, Cagliani R, Cantile M,
Botti G and Russo G: rpL3 promotes the apoptosis of p53 mutated
lung cancer cells by down-regulating CBS and NFκB upon 5-FU
treatment. Sci Rep. 6:383692016. View Article : Google Scholar : PubMed/NCBI
|
